[HTML][HTML] Optogenetic termination of cardiac arrhythmia: mechanistic enlightenment and therapeutic application?

P Sasse, M Funken, T Beiert, T Bruegmann - Frontiers in physiology, 2019 - frontiersin.org
Optogenetic methods enable selective de-and hyperpolarization of cardiomyocytes
expressing light-sensitive proteins within the myocardium. By using light, this technology …

Electrical stimulation for low-energy termination of cardiac arrhythmias: a review

S Buchan, R Kar, M John, A Post, M Razavi - Cardiovascular Drugs and …, 2023 - Springer
Cardiac arrhythmias are a leading cause of morbidity and mortality in the developed world,
estimated to be responsible for hundreds of thousands of deaths annually. Our …

Burden and impact of arrhythmias in repaired tetralogy of Fallot

BL Pinsker, JD Serfas, RA Krasuski - Current Cardiology Reports, 2022 - Springer
Abstract Purpose of Review Arrhythmias are a leading cause of morbidity and mortality
following repair of tetralogy of Fallot (TOF). This review will highlight current understanding …

Technological and clinical challenges in lead placement for cardiac rhythm management devices

M Albatat, J Bergsland, H Arevalo, HH Odland… - Annals of Biomedical …, 2020 - Springer
Cardiac disease is a leading cause of death worldwide. Disturbance in the conduction
system of the heart may trigger or aggravate heart dysfunction, affecting the efficiency of the …

[HTML][HTML] Optimal Timing of Cardioverter-Defibrillator Implantation in Patients with Left Ventricular Dysfunction after Acute Myocardial Infarction

AM Ursaru, II Costache, AO Petris… - Reviews in …, 2022 - imrpress.com
Background: Prevention of sudden cardiac death (SCD) early after acute myocardial
infarction (AMI) is still a challenge, without clear recommendations in spite of the high …

Canine Model of Ischemia-Induced Ventricular Tachycardia

AM Hirahara, MS Khan, Y Ishidoya, D Smego… - Journal of Surgical …, 2024 - Elsevier
Introduction Despite advances in antiarrhythmia therapies, ventricular tachycardia (VT) is a
leading cause of sudden cardiac death. Investigation into the characteristics and new …

Case report: successful termination of ventricular tachycardia by intrinsic anti-tachycardia pacing beyond conventional anti-tachycardia pacing

S Kazawa, K Satomi, H Murakami… - … Heart Journal-Case …, 2023 - academic.oup.com
Background Anti-tachycardia pacing (ATP) is a pain-free alternative to defibrillation shock for
monomorphic ventricular tachycardia (VT). Intrinsic ATP (iATP) is a novel algorithm of auto …

[HTML][HTML] Automatic adjustment of ventricular antitachycardia pacing and individualized device therapy

R Tripathi, C Gubran, C Jeavons - HeartRhythm Case Reports, 2022 - Elsevier
Automatic adjustment of ventricular antitachycardia pacing and individualized device therapy -
ScienceDirect Skip to main contentSkip to article Elsevier logo Journals & Books Search …

[HTML][HTML] Inappropriate implantable cardioverter-defibrillator shocks in repaired tetralogy of fallot patients: Prevalence and electrophysiological mechanisms

IL Goldenthal, MS Rosenbaum, M Lewis… - IJC Heart & …, 2020 - Elsevier
Abstract Background Patients with Tetralogy of Fallot (TOF) are at increased risk for sudden
cardiac death, often undergo implantable cardioverter defibrillator (ICD) implantation at …

Complications related to pacemakers and other cardiac implantable electronic devices: essentials for internists and emergency physicians

LA Arcinas, RS Sheldon - Internal and Emergency Medicine, 2023 - Springer
With the aging population, improving technology, and expanding indications for diagnosing
and treating arrhythmias and heart failure, many patients are receiving cardiac implantable …